Overview
Study information
Network: | CAVD |
Grant Affiliation: | Shattock: Novel Antigens for Mucosal Protection |
Strategy: | Protein & peptide vaccines |
Study Type: | Pre-Clinical Non-NHP |
Species: | Rabbit |
Stage: | Assays Completed |
Study Start Date: | 2006-11-02 |
Study Made Public: | 2011-02-25 |
Title
Neutralization activity of sera collected from rabbits immunized with a recombinant clade C HIV gp140 by the intravaginal route.
Description
CAVD 286 is an immunogenicity study of samples from a preclinical rabbit study of a recombinant Clade C protein.
Sign in to see full information about this study and to download study data.
Products
ZM96 gp140-651.8Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.